RWC: Five stocks to play artificial intelligence in emerging markets

As revealed by RWC EMs team

clock • 4 min read

Artificial intelligence (AI) is set to be a key driver of success in both developed and frontier markets, according to John Malloy and James Johnstone, co-managers of the RWC emerging and frontier markets funds.

Below the duo, who joined RWC Partners in 2015 and now manages over $2.5bn for clients, have identified five companies in emerging markets which are utilising AI who are taking full advantage of this trend. AllianzGI unveils global artificial intelligence fund Alibaba Leveraging its vast amount of sophisticated, transaction-oriented consumer data, we believe Alibaba will be an ultimate beneficiary of AI development. AI allows the company to provide a more personalised experience for its customers; it can rapidly identify clusters and patterns in the information - such as similari...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot